• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER TALISMAN PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER TALISMAN PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-PFO-2518
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Atrial Fibrillation (1729); Bradycardia (1751)
Event Date 06/26/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: crd_806 - pfo occluder pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 25-18mm amplatzer talisman pfo occluder was chosen for a procedure using a 9f amplatzer trevisio intravascular delivery system.During procedure 6000 units of heparin was administrated and electrocardiogram (ecg) showed patient had a atrial fibrillation.A electrical cardioversion performed with 200j at the end of the case.The patient was restored to normal sinus rhythm.On 19 march 2024, a brief episode of palpitations was noted and apple watch tracings reviewed showing sinus brady in the 50-60's.The patient was advised to continue monitoring their heart via apple watch.The patient was reported stable.
 
Manufacturer Narrative
An event of atrial fibrillation was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported event could not be determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER TALISMAN PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19020537
MDR Text Key339129503
Report Number2135147-2024-01476
Device Sequence Number1
Product Code MLV
UDI-Device Identifier05415067033314
UDI-Public(01)05415067033314(17)250831(10)8682241
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number9-PFO-2518
Device Lot Number8682241
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/08/2024
Initial Date FDA Received04/02/2024
Supplement Dates Manufacturer Received04/17/2024
Supplement Dates FDA Received04/29/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age47 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-